(NEXSTAR) – Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to dissolve at a standard rate.

Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, first initiated its recall of the atorvastatin calcium tablets on Sept. 19, 2025, according to an enforcement report from the U.S. Food and Drug Administration.

This month, the recalled drugs were categorized under a “Class II” recall, meaning health officials believe that the use of the affected product “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” according to the FDA.

The recall currently only aff

See Full Page